Israel Englander Mannkind Corp Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Mannkind Corp stock. As of the latest transaction made, Millennium Management LLC holds 3,447,392 shares of MNKD stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,447,392

Previous 1,650,950 108.81%

Holding current value

$19.9 Million

Previous $10.4 Million 113.81%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.44 $10.7 Million - $13.4 Million	1,796,442 Added 108.81%	3,447,392 $22.2 Million
Q3 2024 Nov 14, 2024	SELL	$5.01 - $6.7 $15.5 Million - $20.7 Million	-3,093,569 Reduced 65.2%	1,650,950 $10.4 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $12.6 Million - $16.9 Million	3,107,598 Added 189.84%	4,744,519 $24.8 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $2.45 Million - $3.97 Million	752,916 Added 85.17%	1,636,921 $7.42 Million
Q4 2023 Feb 14, 2024	SELL	$3.34 - $4.29 $2.61 Million - $3.36 Million	-782,864 Reduced 46.97%	884,005 $3.22 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $8.62 Million - $11.1 Million	-2,317,813 Reduced 58.17%	1,666,869 $6.78 Million
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $8.95 Million - $12.8 Million	-2,265,257 Reduced 36.24%	3,984,682 $16.3 Million
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $11.2 Million - $19.8 Million	3,695,224 Added 144.64%	6,249,939 $32.9 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $4.05 Million - $5.89 Million	1,354,513 Added 112.86%	2,554,715 $7.89 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $2.76 Million - $4.93 Million	1,033,915 Added 621.77%	1,200,202 $4.57 Million
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $2.76 Million - $4.68 Million	-1,052,649 Reduced 86.36%	166,287 $612,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $6.07 Million - $8.04 Million	-1,498,083 Reduced 55.14%	1,218,936 $5.33 Million
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $880,050 - $1.24 Million	226,234 Added 9.08%	2,717,019 $11.8 Million
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $1.4 Million - $2.11 Million	-386,902 Reduced 13.44%	2,490,785 $13.6 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $2.53 Million - $4.95 Million	806,828 Added 38.96%	2,877,687 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $3.71 Million - $8.37 Million	2,070,859 New	2,070,859 $6.48 Million
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $4.34 Million - $5.78 Million	-2,780,026 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $1.95 Million - $4.6 Million	2,079,719 Added 296.97%	2,780,026 $4.87 Million
Q1 2020 May 14, 2020	BUY	$0.84 - $1.76 $577,293 - $1.21 Million	687,254 Added 5265.1%	700,307 $721,000
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $670 - $876	-588 Reduced 4.31%	13,053 $17,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.44 $1.1 Million - $1.52 Million	-1,057,426 Reduced 98.73%	13,641 $17,000
Q2 2019 Aug 15, 2019	SELL	$1.09 - $1.88 $596,340 - $1.03 Million	-547,101 Reduced 33.81%	1,071,067 $1.23 Million
Q1 2019 May 14, 2019	BUY	$1.14 - $2.25 $1.84 Million - $3.64 Million	1,618,168 New	1,618,168 $3.19 Million
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $93,461 - $187,839	-91,629 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $79,404 - $172,173	-78,618 Reduced 46.18%	91,629 $168,000
Q2 2018 Aug 14, 2018	SELL	$1.59 - $2.38 $1.38 Million - $2.07 Million	-869,449 Reduced 83.63%	170,247 $323,000
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $2 Million - $3.34 Million	878,432 Added 544.72%	1,039,696 $2.37 Million
Q4 2017 Feb 14, 2018	SELL	$2.28 - $6.71 $1.17 Million - $3.44 Million	-512,779 Reduced 76.08%	161,264 $374,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $775,149 - $1.54 Million	674,043	674,043 $1.46 Million

Others Institutions Holding MNKD

# of Institutions

260

Shares Held

161M

Call Options Held

1.97M

Put Options Held

943K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.48B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account